Overview

PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer

Status:
Terminated
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of PTK787/ZK222584 and Letrozole when given in combination, and to see what effects they have on breast cancer that has metastasized.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Novartis
Treatments:
Letrozole
Vatalanib